{"url_path":"/sec/rdhl/10-k/2026/item-4a","section_key":"item-4a","section_title":"Item 4A UNRESOLVED STAFF COMMENTS**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1553846/0001104659-26-049055-index.html","accession_number":"0001104659-26-049055","cik":"0001553846","ticker":"RDHL","issuer_name":"RedHill Biopharma Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1553846/0001104659-26-049055-index.html","primary_entity_key":"0001553846","primary_entity_name":"RedHill Biopharma Ltd."},"word_count":8,"has_tables":true,"body_markdown":"**ITEM 4A.          UNRESOLVED STAFF COMMENTS**\n\nNot applicable.\n\n​"}